Post stroke depression: clinics, etiopathogenesis and therapeutics

Carregando...
Imagem de Miniatura
Citações na Scopus
12
Tipo de produção
article
Data de publicação
2015
Editora
UNIV SAO PAULO, INST PSIQUIATRIA
Indexadores
Título da Revista
ISSN da Revista
Título do Volume
Autores
PEDROSO, Vinicius Sousa Pietra
SOUZA, Leonardo Cruz de
TEIXEIRA, Antonio Lucio
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
REVISTA DE PSIQUIATRIA CLINICA, v.42, n.1, p.18-24, 2015
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: Stroke is a major cause of morbidity and mortality worldwide. Neuropsychiatric disorders are often associated with stroke and, among them, depression is the most prevalent. Post-stroke Depression (PSD) is related to disability, failure in returning to work, impairment in interpersonal functioning and mortality. Its etiopathogenesis is still uncertain, as well as its treatment. In Brazil, there are few data on the impact of PSD. Objective: This work is dedicated to conduct a comprehensive review of the concept of PSD, its pathophysiology, morbidity and treatment. Methods: PubMed, Medline and Lilacs searches of relevant terms yielded 3,265 papers in the last 10 years. We selected original studies and reviews that addressed the aspects mentioned above. Results: We present the history of the notion of PSD and describe its epidemiology, looking to highlight Brazilian studies. Diagnostic criteria and clinical presentation were detailed, with emphasis on cognitive aspects. The four main pathophysiological theories proposed to PSD are presented and we discuss the various treatment strategies, involving psychopharmacologic options, brain stimulation techniques and psychotherapy. Discussion: This work provides comprehensive information on PSD, of great utility for clinical practice and research in this topic.
Palavras-chave
Stroke, cerebrovascular diseases, depression, post-stroke depression, vascular depression
Referências
  1. Alexopoulos GS, 1997, ARCH GEN PSYCHIAT, V54, P915
  2. American Heart Association Statistics Committee and Stroke Statistics Subcommittee, 2013, CIRCULATION, V127, pe6
  3. American Psychiatric Association, 2013, DIAGN STAT MAN MENT
  4. Angelelli P, 2004, ACTA PSYCHIAT SCAND, V110, P55, DOI 10.1111/j.1600-0447.2004.00297.x
  5. Ayerbe L, 2013, BRIT J PSYCHIAT, V202, P14, DOI 10.1192/bjp.bp.111.107664
  6. Ayerbe L, 2013, STROKE, V44, P1105, DOI 10.1161/STROKEAHA.111.679340
  7. Bozikas VP, 2005, AM J GERIAT PSYCHIAT, V13, P166, DOI 10.1176/appi.ajgp.13.2.166
  8. BRYER JB, 1992, J NEUROPSYCH CLIN N, V4, P440
  9. Bueno VF, 2011, NEUROCASE, V17, P318, DOI 10.1080/13554794.2010.509319
  10. Carod-Artal FJ, 2009, J NEUROL SCI, V284, P63, DOI 10.1016/j.jns.2009.04.008
  11. Carson AJ, 2000, LANCET, V356, P122, DOI 10.1016/S0140-6736(00)02448-X
  12. Chollet F, 2011, LANCET NEUROL, V10, P123, DOI 10.1016/S1474-4422(10)70314-8
  13. Clarke DM, 2002, AUST NZ J PSYCHIAT, V36, P733, DOI 10.1046/j.1440-1614.2002.01086.x
  14. Craft TKS, 2006, BIOL PSYCHIAT, V60, P812, DOI 10.1016/j.biopsych.2006.03.011
  15. Cumming TB, 2010, ACTA PSYCHIAT SCAND, V121, P424, DOI 10.1111/j.1600-0447.2010.01558.x
  16. de Carvalho JJF, 2011, STROKE, V42, P3341, DOI 10.1161/STROKEAHA.111.626523
  17. Fabregas BC, 2012, GEN HOSP PSYCHIAT, V34, P40, DOI 10.1016/j.genhosppsych.2011.09.002
  18. FEDOROFF JP, 1991, AM J PSYCHIAT, V148, P1172
  19. FOLSTEIN MF, 1977, J NEUROL NEUROSUR PS, V40, P1018, DOI 10.1136/jnnp.40.10.1018
  20. Froes KSDO, 2011, ARQ NEURO-PSIQUIAT, V69, P371, DOI 10.1590/S0004-282X2011000300020
  21. Gainotti G, 1999, BRIT J PSYCHIAT, V175, P163, DOI 10.1192/bjp.175.2.163
  22. Hackett ML, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003689.pub3
  23. Hackett ML, 2005, STROKE, V36, P1330, DOI 10.1161/01.STR.0000165928.19135.35
  24. Hackett ML, 2009, STROKE, V40, pE487, DOI 10.1161/STROKEAHA.109.547059
  25. Jimenez I, 2009, PSYCHOL MED, V39, P1201, DOI 10.1017/S0033291709005637
  26. Jorge RE, 2008, ARCH GEN PSYCHIAT, V65, P268, DOI 10.1001/archgenpsychiatry.2007.45
  27. Kauhanen ML, 1999, STROKE, V30, P1875
  28. Kim BR, 2010, AM J PHYS MED REHAB, V89, P362, DOI 10.1097/PHM.0b013e3181d8a5b1
  29. Kim JM, 2012, WORLD J BIOL PSYCHIA, V13, P579, DOI 10.3109/15622975.2011.588247
  30. Kim JM, 2012, J AFFECT DISORDERS, V136, P833, DOI 10.1016/j.jad.2011.09.029
  31. Kohen R, 2011, STROKE, V42, P2068, DOI 10.1161/STROKEAHA.110.611434
  32. Lieberman D, 1999, DISABIL REHABIL, V21, P542
  33. Makikallio AM, 2004, NEUROLOGY, V62, P1822
  34. Mead GE, 2013, STROKE, V44, P844, DOI 10.1161/STROKEAHA.112.673947
  35. Moller M, 2007, ACTA NEUROL SCAND, V116, P83, DOI 10.1111/j.1600-0404.2007.00869.x
  36. Mössner Rainald, 2007, World J Biol Psychiatry, V8, P141, DOI 10.1080/15622970701263303
  37. Nys GMS, 2005, J NEUROL SCI, V228, P27, DOI 10.1016/j.jns.2004.09.031
  38. Nys GMS, 2006, J NEUROL SCI, V247, P149, DOI 10.1016/j.jns.2006.04.005
  39. O'Connor JC, 2009, MOL PSYCHIATR, V14, P511, DOI 10.1038/sj.mp.4002148
  40. Oldehinkel AJ, 2003, J AFFECT DISORDERS, V74, P237, DOI 10.1016/S0165-0327(02)00014-9
  41. Paolucci S, 2006, J NEUROL, V253, P556, DOI 10.1007/s00415-006-0058-6
  42. Price A, 2011, J NEUROL NEUROSUR PS, V82, P914, DOI 10.1136/jnnp.2010.230862
  43. Ramasubbu R, 2006, J NEUROPSYCH CLIN N, V18, P96, DOI 10.1176/appi.neuropsych.18.1.96
  44. Rangel ESS, 2013, ACTA PAUL ENFERM, V26, P205, DOI 10.1590/S0103-21002013000200016
  45. Robinson RG, 2008, AM J GERIAT PSYCHIAT, V16, P867, DOI 10.1097/JGP.0b013e318180057d
  46. ROBINSON RG, 1977, BIOL PSYCHIAT, V12, P669
  47. Robinson RG, 2006, CLIN NEUROPSYCHIATRY
  48. Scheffer Morgana, 2011, Psychol. Neurosci., V4, P267, DOI 10.3922/j.psns.2011.2.012
  49. Shader RI, 2005, J CLIN PSYCHOPHARM, V25, P291, DOI 10.1097/01.jcp.0000172072.58388.74
  50. Simis S, 2006, ARQ NEURO-PSIQUIAT, V64, P412, DOI 10.1590/S0004-282X2006000300012
  51. Souza Aline Cristina de, 2013, J Neurol Sci, V324, P34, DOI 10.1016/j.jns.2012.09.022
  52. Spalletta G, 2013, J NEUROPSYCH CLIN N, V25, P255, DOI 10.1176/appi.neuropsych.12120399
  53. Spalletta G, 2010, ACTA PSYCHIAT SCAND, V121, P401, DOI 10.1111/j.1600-0447.2010.01569.x
  54. Spalletta G, 2006, MOL PSYCHIATR, V11, P984, DOI 10.1038/sj.mp.4001879
  55. Tang WK, 2013, GENET MOL RES, V12, P1546, DOI 10.4238/2013.May.13.8
  56. Terroni LDN, 2009, REV BRAS PSIQUIATR, V31, P202, DOI 10.1590/S1516-44462009000300004
  57. Tokgozoglu SL, 1999, STROKE, V30, P1307
  58. Yang LL, 2010, NEUROL RES, V32, P340, DOI 10.1179/016164110X12656393665080
  59. Zhou ZM, 2011, CLIN CHEM LAB MED, V49, P185, DOI 10.1515/CCLM.2011.039